- |||||||||| Vyrologix (leronlimab) / CytoDyn, Vyera Pharma, amfAR
EUA LERONLIMAB NOW (Twitter) - Apr 6, 2021
- |||||||||| Vyrologix (leronlimab) / CytoDyn, Vyera Pharma, amfAR
EUA LERONLIMAB (Twitter) - Mar 21, 2021
- |||||||||| Vyrologix (leronlimab) / CytoDyn, Vyera Pharma, amfAR
Leronlimab (Twitter) - Mar 19, 2021
- |||||||||| Vyrologix (leronlimab) / CytoDyn, Vyera Pharma, amfAR
Leronlimab (Twitter) - Mar 18, 2021
- |||||||||| Vyrologix (leronlimab) / CytoDyn, Vyera Pharma, amfAR
Clinical, Clinical data, P2 data, P3 data: "Who knows?" We studied leronlimab, an humanized IgG4 mAb, HIV chemokine coreceptor blocker for mild to mod COVID (Phase 2). Modulates T cell trafficking, cytokines. Data showed some good clinical outcomes but small dataset. Phase 3 for severe disease is ongoing, looks promising. (Twitter) - Mar 14, 2021
- |||||||||| Vyrologix (leronlimab) / CytoDyn, Vyera Pharma, amfAR
Leronlimab (Twitter) - Mar 10, 2021
- |||||||||| Vyrologix (leronlimab) / CytoDyn, Vyera Pharma, amfAR
Leronlimab....cmon (Twitter) - Mar 6, 2021
- |||||||||| Real Help, Live Up to It! AGT103-T Vacc-C5, Vacc-4x, Pro140, OyaGen HIV eradication, eCD4-Ig Farzan protein, FIT Biotech(now disappeared), Dermavir, N6 antibody, VRC01, SP-01A, VDA KP-1461 Mosaico Ragon institute block n lock gene deserts moved toward vaccine elite control (Twitter) - Mar 1, 2021
|